Socialist Party deputy Juan Luis Castro has revealed his growing suspicions regarding possible price-fixing between several laboratories across the country, representing much of Chile’s pharmaceutical industry. The congressman has pointed to a 42% increase in the prices of 16 of the country’s 20 most-used medications, all during a short period between 2015 and 2016.
Castro, who is a member of the Health Commission, believes that “this increase in the price of 20 of Chile’s most consumed medications is a low blow to the middle class and all popular sectors, since it implies increases in common remedies such as paracetamol, ibuprofen, loratadine, salbutamol and many other daily-use substances.”
Castro announced his intentions to “take these findings to the Public Health Institute and the National Economic Prosecutor, because there probably are signs of collusion, agreements to raise prices in their products, as has already been seen with drugstores and which may now be occurring between laboratories.”
Full Content: Terra
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI